HomeInsightsStock Comparison

Cohance Lifesciences Ltd vs Sai Life Sciences Ltd Stock Comparison

Cohance Lifesciences Ltd vs Sai Life Sciences Ltd Stock Comparison

Last Updated on: Aug 02, 2025

Key Highlights

  • The Latest Trading Price of Cohance Lifesciences Ltd is ₹ 980.4 as of 01 Aug 15:30.
  • The P/E Ratio of Cohance Lifesciences Ltd changed from 8.1 on March 2020 to 57.3 on March 2024 . This represents a CAGR of 47.89% over 5 yearsThe P/E Ratio of Sai Life Sciences Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The Market Cap of Cohance Lifesciences Ltd changed from ₹ 2564 crore on March 2020 to ₹ 17223 crore on March 2024 . This represents a CAGR of 46.37% over 5 yearsThe Market Cap of Sai Life Sciences Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The revenue of Cohance Lifesciences Ltd for the Mar '25 is ₹ 412.59 crore as compare to the Dec '24 revenue of ₹ 322.86 crore. This represent the growth of 27.79% The revenue of Sai Life Sciences Ltd for the Mar '25 is ₹ 589.11 crore as compare to the Dec '24 revenue of ₹ 448.89 crore. This represent the growth of 31.24%.
  • The ebitda of Cohance Lifesciences Ltd for the Mar '25 is ₹ 84.13 crore as compare to the Dec '24 ebitda of ₹ 133.41 crore. This represent the decline of -36.94% The ebitda of Sai Life Sciences Ltd for the Mar '25 is ₹ 167.17 crore as compare to the Dec '24 ebitda of ₹ 128.87 crore. This represent the growth of 29.72%.
  • The net profit of Cohance Lifesciences Ltd changed from ₹ 46.75 crore to ₹ 38.73 crore over 8 quarters. This represents a CAGR of -8.98% The net profit of Sai Life Sciences Ltd changed from ₹ 39.61 crore to ₹ 88.27 crore over 8 quarters. This represents a CAGR of 49.28% .
  • The Dividend Payout of Cohance Lifesciences Ltd changed from 23.57 % on March 2020 to 0 % on March 2024 . This represents a CAGR of -100.00% over 5 yearsThe Dividend Payout of Sai Life Sciences Ltd changed from 443.82 % on March 2022 to 0 % on March 2024 . This represents a CAGR of -100.00% over 3 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Cohance Lifesciences Ltd

  • Suven Pharmaceuticals Limited (SPL) is an integrated Contract Development and Manufacturing Operations (CDMO) company that serves leading global life science and fine chemical majors.
  • The Company's comprehensive services encompass- Custom Synthesis, Process R&D, Scale-Up, and Contract Manufacturing of intermediates, APIs, and formulations. Suven Pharmaceuticals Limited was incorporated on 6 November, 2018 and is engaged in the business of development and manufacturing of New Chemical Entity (NCE) based Intermediates, Active Pharmaceutical Ingredients (API), Speciality Chemicals and formulated drugs under contract research and manufacturing services for global pharmaceutical, biotechnology and chemical companies.
  • The Company has established core competencies in cyanation and heterocyclic chemistry, covering pyrimidines, quinolones, thiazoles, and imidazoles.

About Sai Life Sciences Ltd

  • Sai Life Sciences Limited was originally incorporated as Sai Dru Syn Laboratories Limited' as a Public Limited Company, dated January 25, 1999, issued by the Registrar of Companies, Andhra Pradesh at Hyderabad.
  • The Company received the Certificate of Commencement of Business from Registrar of Companies, Andhra Pradesh on February 17, 1999.
  • Subsequently, the Company name was changed from Sai Dru Syn Laboratories Limited' to Sai Life Sciences Limited' dated December 16, 2003. Thereafter, the name of the Company was changed from Sai Life Sciences Limited' to Sai Advantium Pharma Limited' dated August 30, 2006 issued by the Registrar of Companies, Andhra Pradesh.
  • Subsequently, the Company name was changed from Sai Advantium Pharma Limited' to Sai Life Sciences Limited' and a fresh Certificate of Incorporation dated May 28, 2012 was issued by the Registrar of Companies, Andhra Pradesh at Hyderabad.

Cohance Lifesciences Ltd News Hub

News

Cohance Lifesciences appoints Yann D'Herve as CEO - CDMO Business

The Board of Cohance Lifesciences has appointed Yann D'Herve as Chief Executive Officer - ...

Read more

28 Jul 2025 18:56

News

Cohance Lifesciences announces resignation of CEO

Cohance Lifesciences announced the resignation of Dr. Sudhir Kumar Singh, who looks after ...

Read more

28 Jul 2025 18:52

News

Cohance Lifesciences to announce Quarterly Result

Cohance Lifesciences will hold a meeting of the Board of Directors of the Company on 13 Au...

Read more

28 Jun 2025 09:56

News

Cohance Lifesciences to hold AGM

Cohance Lifesciences announced that the 7th Annual General Meeting(AGM) of the company wil...

Read more

27 Jun 2025 15:41

News

Cohance Lifesciences' API Unit-IV clears USFDA inspection

Cohance Lifesciences has received the Establishment Inspection Report (EIR) from the Unite...

Read more

26 May 2025 08:46

News

Suven Pharmaceuticals allots 12.80 cr equity shares

Suven Pharmaceuticals has allotted 12,80,02,184 equity shares of the Company of face value...

Read more

09 May 2025 09:58

Sai Life Sciences Ltd News Hub

News

Sai Life Sciences to convene board meeting

Sai Life Sciences will hold a meeting of the Board of Directors of the Company on 7 August...

Read more

22 Jul 2025 10:46

News

Sai Life Sciences rises on completion of second phase expansion at Bidar facility

The new phase, which became operational on 19 June 2025, adds approximately 91 kL of produ...

Read more

20 Jun 2025 14:49

News

Board of Sai Life Sciences approves allotment of 19,000 equity shares under EOSP

The Board of Sai Life Sciences at its meeting held on 09 June 2025 has approved and allott...

Read more

09 Jun 2025 19:33

News

Sai Life Sciences allots 25,000 equity shares under ESOPs

Sai Life Sciences has allotted 25,000 equity shares under ESOPs on 13 May 2025. Powered by...

Read more

14 May 2025 09:28

News

Sai Life Sciences jumps after stellar results

EBITDA jumped 42% year-on-year (YoY) to Rs 425 crore in FY25. EBITDA margin improved to 25...

Read more

14 May 2025 16:16

News

Sai Life Sciences to announce Quarterly Result

Sai Life Sciences will hold a meeting of the Board of Directors of the Company on 13 May 2...

Read more

08 May 2025 11:19

SWOT Analysis Of Cohance Lifesciences Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of Sai Life Sciences Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Cohance Lifesciences Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Cohance Lifesciences Ltd and Sai Life Sciences Ltd

Which company has a larger market capitalization, Cohance Lifesciences Ltd or Sai Life Sciences Ltd?

Market cap of Cohance Lifesciences Ltd is 37,506 Cr while Market cap of Sai Life Sciences Ltd is 16,399 Cr

What are the key factors driving the stock performance of Cohance Lifesciences Ltd and Sai Life Sciences Ltd?

The stock performance of Cohance Lifesciences Ltd and Sai Life Sciences Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Cohance Lifesciences Ltd and Sai Life Sciences Ltd?

As of August 2, 2025, the Cohance Lifesciences Ltd stock price is INR ₹980.4. On the other hand, Sai Life Sciences Ltd stock price is INR ₹785.6.

How do dividend payouts of Cohance Lifesciences Ltd and Sai Life Sciences Ltd compare?

To compare the dividend payouts of Cohance Lifesciences Ltd and Sai Life Sciences Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions